ライフサイエンスコーパス: high income

1 income and 0.4 percentage point increase for high income).

2 kelihood of complete remission, or survival (high income: adjusted HR, 1.0; medium income: adjusted H

3 expectancy has risen among middle-income and high-income Americans whereas it has stagnated among poo

4 tients with CVRDs exist between countries of high income and countries of low and middle income.

5 d neighborhoods in 13 different countries (9 high-income and 4 middle-income).

6 ancer registries remains a challenge in both high-income and low and middle-income countries.

7 globally, with striking disparities between high-income and low- to middle-income countries.

8 ountries, without a clear difference between high-income and middle-income countries.

9 t consistent differences in outcomes between high-income and middle-income countries.

10 view and 172 additional studies, covering 27 high-income and seven middle-income countries.

11 igh-income North America (310, 140-400), and high-income Asia Pacific (300, 140-370).

12 ]), whereas the largest decrease occurred in high-income Asia Pacific (APC = -2.88% [-3.58 to -2.18%]

13 valence of insufficient activity in 2016 was high-income Asia Pacific for both boys (89.0%, 62.8-92.2

14 population and 3 supplemental cohorts (with high income, cancer, and with heart disease, respectivel

15 nterest messaging, performing much better in high-income communities than low- and moderate-income co

16 tion, reducing early-onset infant disease in high-income contexts.

17 m subsidies (251%-400% FPL) were compared to high-income controls ineligible for subsidies (>400% FPL

18 udies (92%) were conducted on populations in high-income counties, cardiovascular disease was the mos

19 Evidence from high income countries (HICs) suggests that individuals w

20 evidence for this is confined to studies in high income countries and the evidence is not sufficient

21 These findings suggest that tap water in high income countries could serve as an important source

22 Trachoma disappeared from high income countries through enhancements of hygiene an

23 pted estimates for the general population in high income countries.

24 o navigate health services in the context of high income countries.

25 for refugee women seeking maternity care in high income countries.

26 of refugee women accessing maternity care in high income countries.

27 th cataracts in our setting is older than in high income countries.

28 0.8 million [34.6-92.9] DALYs) compared with high-income countries (0.09 million [0.01-0.40] DALYs).

29 panding PET would yield the largest gains in high-income countries (0.2, 0.0-0.8).

30 1-0.83; k=23; I(2)=77%) but not among MSM in high-income countries (0.99, 0.90-1.09; k=20; I(2)=40%).

31 with four drug classes available was 94% in high-income countries (108 of 115 communities), 76% in I

32 ctions (group median 17.9% [12.3-20.5]) than high-income countries (14.1% [6.6-17.8]).

33 d upper-middle-income countries and lower in high-income countries (18.5, 15.2, and 9.0 per 1000 vent

34 n LMICs (31.5%, 1.04 billion people) than in high-income countries (28.5%, 349 million people).

35 ntries (5602 of 65 471), and less than 1% in high-income countries (44 of 10 880).

36 Most were conducted in high-income countries (60.7%) and in adult ICUs (85.2%).

37 pulation attributable fraction was higher in high-income countries (79%, 95% CrI 57-97) than in count

38 A significant association was observed in high-income countries (cOR = 0.24, 95% CI: .13-.45; I2 =

39 lombia, India, Jordan and Sri Lanka), and 11 high-income countries (Denmark, Finland, Germany, Greece

40 ajor geo-economic groupings, namely European high-income countries (Europe-High), high-income countri

41 e present in 80% to 90% of suicide deaths in high-income countries (HIC), but this association is les

42 rticularly haemodialysis and most notably in high-income countries (HICs) - the rate of true patient-

43 threshold for high risk of at least 10% for high-income countries (HICs) and at least 20% for low-in

44 ipheral artery disease was estimated in both high-income countries (HICs) and low-income and middle-i

45 d 80% for the 45,000 children with cancer in high-income countries (HICs) but are less than 30% for t

46 of common diseases and related mortality in high-income countries (HICs), middle-income countries (M

47 ave been exclusively developed and tested in high-income countries (HICs).

48 e associated with lifestyles commonly led in high-income countries (HICs; also known as western disea

49 England and Wales with median values for 22 high-income countries (in western Europe, Australia, Can

50 these estimates with international data from high-income countries (Norway and the USA).

51 g Partnership (ICBP), the Cancer Survival in High-Income Countries (SURVMARK-2) project aims to provi

52 els appeared to differ by geographic region (high-income countries 64.5%, low-income countries 9.1%),

53 prevalence of overuse is well documented in high-income countries across a wide range of services an

54 er (HPV-OPC) incidence is increasing in many high-income countries among men.

55 ive overview of cancer survival across seven high-income countries and a comparative assessment of co

56 All studies were published in high-income countries and examined policies of entry (ni

57 o suggest criteria (discussed separately for high-income countries and for low- and middle-income cou

58 idence of the effects of integrating care in high-income countries and in low-income and middle-incom

59 gth of the evidence base for these models in high-income countries and in low-income and middle-incom

60 ry in Africa is 50 times higher than that of high-income countries and is driven by peripartum haemor

61 and middle-income countries (LMICs) than in high-income countries and is rising.

62 fant mortality have persisted for decades in high-income countries and may have become stronger in so

63 recommendations might be more applicable to high-income countries and might not be generalisable bec

64 compared to conventional drinking waters in high-income countries and more closely resembled chlorin

65 of patients worldwide based on prevalence in high-income countries and prevalence at birth.

66 athogen are different from those observed in high-income countries and provide a baseline for studies

67 work to examine the approaches taken by nine high-income countries and regions that have started to e

68 then aggregated to seven regions: World Bank high-income countries and the six WHO regions (ie, Afric

69 High-income countries are experiencing measles reemergen

70 t increase), whereas upper-middle-income and high-income countries are more likely to benefit from im

71 in childhood in term-born children living in high-income countries are not well known.

72 known kidney risk factors (case finding) in high-income countries as well as in low- and middle-inco

73 fections has decreased in people with HIV in high-income countries because of the widespread availabi

74 tainty interval 40.3-44.3), with survival in high-income countries being an average of 12 times (rang

75 tly associated with lower food insecurity in high-income countries but corresponded to increased food

76 ortality has declined over recent decades in high-income countries but increased in low- and middle-i

77 costs a small fraction of average incomes in high-income countries but is not affordable for the worl

78 global donor pool, and so benefits people in high-income countries by improving their chances of find

79 es of disease burden have been reported from high-income countries compared with reports from low-inc

80 the most commonly diagnosed bacterial STI in high-income countries despite widespread testing recomme

81 re difficult to achieve for many patients in high-income countries even before the pandemic, and ther

82 ways to lessen the divide between LMICs and high-income countries for breast and cervical cancers.

83 ralian experience with PCV7 and reports from high-income countries giving a PCV booster dose.

84 3-valent PCV (PCV13) in 2011, uniquely among high-income countries giving doses at 2, 4, and 6 months

85 70%) upper-middle-income, and 40 of 44 (91%) high-income countries had any IAP policy.

86 Our findings suggest that people in high-income countries have better access to sexual and r

87 ale antibiotic sales in 70 middle-income and high-income countries in 2015.

88 We collected data for prison suicides in 24 high-income countries in Europe, Australasia, and North

89 r childbirth has been diminishing in several high-income countries in recent decades, the evidence on

90 unities in 18 low-income, middle-income, and high-income countries in seven geographical regions: Nor

91 uropean high-income countries (Europe-High), high-income countries in the rest of the world (rWORLD-H

92 The life expectancy disadvantage for high-income countries is 30% for hemophilia A, 37% for s

93 detailed information about antibiotic use in high-income countries is available, little is known rega

94 The reduced environmental impact in high-income countries is driven by reductions in calorie

95 n Africa (2.76 per 100 women), compared with high-income countries like the United States (1.69 per 1

96 ure of the studies included and the focus on high-income countries limit the conclusions of this revi

97 gies aimed at reducing neonatal mortality in high-income countries may need to address socially relat

98 The United States is one of the few high-income countries not to apply economic evaluation r

99 n hard-to-reach (underserved) populations in high-income countries of low tuberculosis incidence.

100 ults aged 35-70 y from 16 low-, middle-, and high-income countries on 5 continents.

101 ta to calculate these risk factors come from high-income countries only.

102 age-specific incidence rates of dementia in high-income countries over time.

103 Although high-income countries pioneered 1960s precautionary anti

104 ncluded empirical observational studies from high-income countries reporting an association between S

105 Comparisons with other high-income countries reveal that the US CVD stagnation

106 etiological epidemiology within academia in high-income countries shifted its primary concern from a

107 pidemiological studies conducted in low- and high-income countries showed that infants exposed to mat

108 our current knowledge is mainly derived from high-income countries such in Europe and North-America,

109 Data from high-income countries suggest increasing hepatitis C vir

110 Policy consensus in high-income countries supports offering pregnant women w

111 greater proportion of the economic burden in high-income countries than in low-income countries.

112 mplementation scores tended to be highest in high-income countries that invest in health care and edu

113 STMs send physicians from high-income countries to low and middle-income countries

114 ation screening for SGA has been proposed in high-income countries to prevent perinatal morbidity and

115 settings, from tertiary referral centres in high-income countries to resource limited environments i

116 Estimated survival gains in high-income countries were very modest.

117 : Most surgeons from high-income countries who work in global surgery will do

118 might lead to a reduction in tuberculosis in high-income countries with a low incidence of the diseas

119 However, among households in high-income countries with incomes higher than US$25 430

120 Social inequalities in mortality persist in high-income countries with universal health care, and th

121 ildhood infection-related hospitalisation in high-income countries with varying CS rates.

122 rth cohort studies from the low, middle, and high-income countries worldwide and 2) describe similari

123 regions and 25 countries (most of which are high-income countries) are on track to achieve SDG targe

124 countries from a mix of low- to middle- and high-income countries) collaborated, with 141,220 partic

125 improving the quality of care to the mean of high-income countries) implemented in isolation or as pa

126 curs despite high service coverage (often in high-income countries).

127 f education) was 1.23 (95% CI 0.96-1.58) for high-income countries, 1.59 (1.42-1.78) in middle-income

128 mortality, with HRs of 1.50 (1.14-1.98) for high-income countries, 1.80 (1.58-2.06) in middle-income

129 In high-income countries, 2 in 3 individuals with cerebral

130 Among high-income countries, a higher upper age limit was asso

131 Unlike other high-income countries, age-adjusted mortality in the USA

132 Centre-based care has become the norm in high-income countries, allowing patients to benefit from

133 of studies which were primarily conducted in high-income countries, and a narrow range of early-life

134 increases in the USA is extremely unusual in high-income countries, and a rapid public health respons

135 s-long rise for almost all countries outside high-income countries, and alarmingly, the age-standardi

136 <1 in 1 000 000 in the United States, other high-income countries, and in high-incidence regions per

137 es for patients with cystic fibrosis between high-income countries, and low-income and middle-income

138 e systems are generally weaker than those in high-income countries, and patients often present at adv

139 ty outcomes, were published in English, from high-income countries, and were done in populations with

140 on emission CT [SPECT]) to the mean level of high-income countries, both individually and in combinat

141 n part higher productivity (and earnings) in high-income countries, but also prominently higher treat

142 development have been extensively studied in high-income countries, but few data are available from l

143 eased as the level of education increased in high-income countries, but increased as the level of edu

144 nfant mortality has almost been abolished in high-income countries, but only a small amount of progre

145 In high-income countries, cervical cancer incidence and mor

146 In high-income countries, drinking water is often neglected

147 sexual, and other non-heterosexual women) in high-income countries, few studies of sexual minority wo

148 In most high-income countries, health care is considered a human

149 y decreased over the last several decades in high-income countries, in circumstances when delays in t

150 In high-income countries, inflammation has been associated

151 In high-income countries, low SEP is a risk factor for hosp

152 Like high-income countries, low-income countries typically ar

153 In high-income countries, obesity prevalence (body mass ind

154 if they were of deminers, if they were from high-income countries, or if they were of chemical weapo

155 In high-income countries, recent reviews have demonstrated

156 Our findings are distinct from evidence from high-income countries, suggesting the importance of broa

157 In high-income countries, the biggest cause of premature de

158 In high-income countries, the current treatment-dominated,

159 In high-income countries, the leading causes of death are n

160 In high-income countries, the presentation of tuberculosis

161 eatment were commensurate with those in some high-income countries, the proportion of participants wh

162 es were consistent with those encountered in high-income countries, the specific behaviors associated

163 We excluded studies in high-income countries, those involving non-pregnant wome

164 in carriers are currently advocated in most high-income countries, to prevent cross-transmission and

165 s an ageing population and dietary habits of high-income countries, unfavourable risk factors such as

166 fect against cardiovascular disease (CVD) in high-income countries, where physical activity is mainly

167 ly at premenopausal ages largely occurred in high-income countries, whereas the increasing postmenopa

168 bient air pollution exposure have focused on high-income countries, which have much lower pollutant c

169 lso completed a desk review of 10 additional high-income countries, which were also included.

170 tcomes than the health-care systems in other high-income countries, while leaving a substantial propo

171 Examples of successful high-income countries-LMIC partnerships are provided.

172 pendent on opioids, coverage is low, even in high-income countries.

173 avior due to impaired water, particularly in high-income countries.

174 five low-income, 11 middle-income, and four high-income countries.

175 immunogenic in low- or middle-income than in high-income countries.

176 at ten times higher prevalence compared with high-income countries.

177 ficiency virus (HIV)-infected populations in high-income countries.

178 All studies were from high-income countries.

179 ohort or case-control studies carried out in high-income countries.

180 ican countries is large, and greater than in high-income countries.

181 and middle-income countries compared with in high-income countries.

182 s just under 1%, but estimates are higher in high-income countries.

183 sed with cancer is approximately 80% in many high-income countries.

184 sing freely available mortality data from 13 high-income countries.

185 ong term and in relation to a group of other high-income countries.

186 e-income countries, and 79.4% (74.0-86.2) in high-income countries.

187 re linked to poor migrant health outcomes in high-income countries.

188 dle-income countries, although it is rare in high-income countries.

189 evalence estimates being approximately 5% in high-income countries.

190 lawian ART users does not yet mirror that in high-income countries.

191 er than among the general population in many high-income countries.

192 ment compared with that in middle-income and high-income countries.

193 use and by the neglect of typhoid outside of high-income countries.

194 ome countries and no or minor differences in high-income countries.

195 this hypothesis has been derived solely from high-income countries.

196 orted causes of direct maternal mortality in high-income countries.

197 er in Denmark and England than in comparable high-income countries.

198 d occurs at lower rates in middle-income and high-income countries.

199 tries (LMICs) is dramatically higher than in high-income countries.

200 tion, but it is restricted to adult women in high-income countries.

201 ounterparts or among the host populations in high-income countries.

202 as larger in middle-income countries than in high-income countries.

203 ure documenting similar disparities in other high-income countries.

204 Mortality was high in comparison to high-income countries.

205 le-income countries, and 164 (46%) were from high-income countries.

206 -income countries (except for India) than in high-income countries.

207 ncome countries, and 7.0 years (3.6-16.8) in high-income countries.

208 middle-income countries, and 114 (70%) from high-income countries.

209 approximately 20% of the adult population in high-income countries.

210 ividuals from low-income, middle-income, and high-income countries.

211 obesity among food-insecure women living in high-income countries.

212 ncardiovascular causes in low-, middle-, and high-income countries.

213 fatality rates than those currently seen in high-income countries.

214 een increasing worldwide and particularly in high-income countries.

215 hildren and those in upper-middle-income and high-income countries.

216 with point prevalence estimates being ~5% in high-income countries.

217 multicountry sample of 23 upper-middle- and high-income countries.

218 vidence is scarce and mostly originates from high-income countries.

219 cular disease differs between low-income and high-income countries.

220 er doses offered by upper-middle-income than high-income countries.

221 cations where it was previously declining in high-income countries.

222 % UI 191-303) across upper-middle-income and high-income countries.

223 e diseases observed over the past decades in high-income countries.

224 amatically improved the outcomes of STEMI in high-income countries.

225 ecame the most common AIDS-related cancer in high-income countries.

226 n 20 globally and as many as one in eight in high-income countries.

227 eta-analysis, and included 65 articles in 14 high-income countries: 23 for HPV infection, 29 for anog

228 ning is not a wise use of resources, even in high-income countries; and that screening has substantia

229 V) vaccination have been implemented in most high-income countries; however, coverage is low in low-i

230 Cancer survival continues to increase across high-income countries; however, international disparitie

231 rally not been found to be cost-effective in high-income countries; however, this assessment has rare

232 ed on measurements of potassium accretion in high-income country (HIC) pregnant women.

233 ared to HIV-unexposed (HU) infants born in a high-income country (HIC).

234 Singapore is a high-income country in a region with a high prevalence o

235 r acute coronary syndrome quality of care in high-income country settings, further research will help

236 rove acute coronary syndrome care largely in high-income country settings.

237 ntacts for 965 individuals in 2017/2018 in a high-income densely-populated area of China, Shanghai Ci

238 High-income east Asian countries are also at this stage,

239 ntal outcomes between children from low- and high-income families.

240 ts were divided into the following 3 groups: high income (family income to poverty ratio, >/=4), midd

241 rages than non-Hispanic white households and high-income households (all P < 0.01).These results prov

242 Children living in areas of high income inequality have higher rates of hospitalizat

243 rtiles for low, low-middle, high-middle, and high income inequality.

244 ACSCs should consider focusing on areas with high income inequality.

245 ents with HFrEF from low-income regions with high income inequality.

246 Diseases associated with high-income lifestyles are the most serious threat to he

247 nts by matching donor-recipient pairs across high-income, medium-income, and low-income countries.

248 vity of patients with sickle cell disease in high-income, middle-income, and low-income countries pre

249 mic status-wealth and education-differ among high-income, middle-income, and low-income countries, an

250 or history of cardiovascular disease from 21 high-income, middle-income, or low-income countries (HIC

251 The United States is the only high-income nation without universal, government-funded

252 ow that compared with average diets, NRDs in high-income nations are associated with reductions in GH

253 vidence is mostly based on case studies from high-income nations using widely varying constraints and

254 ith the same material aspirations of today's high-income nations, there is no question: The future ec

255 Individuals in high-income neighbourhoods increased their days at home

256 merica (340 cases per year, 95% UI 150-440), high-income North America (310, 140-400), and high-incom

257 ities in developed regions (i.e., Europe and high-income North America) decreased substantially by 67

258 In New York and London, individuals in high-income occupations are concentrating in the city ce

259 r analysis shows an increase in the share of high-income occupations, accompanied by a fall in low-in

260 willingness to seek regionalized care, while high income (OR 2.09, 95% CI 1.39-3.16) was associated w

261 working-age women (mean age, 18-65 years) in high-income Organization for Economic Co-operation and D

262 olic health sequelae of working-age women in high-income Organization for Economic Co-operation and D

263 ed low-income, low-middle-income, and middle-high-income participants in the NSLP compared with nonpa

264 d among those with low incomes compared with high-income populations.

265 of PCVs on pneumonia is similar in low- and high-income populations.

266 ons for all-cause pneumonia in both low- and high-income populations.

267 ns (from 0% in sub-Saharan Africa to 2.3% in High Income Region).

268 ite race, older age, higher body mass index, high-income region of enrollment, hypertension, and teno

269 Health Organization Global Burden of Disease high-income regions).

270 dence of liver and pancreatic cancer in some high-income regions.

271 nd (803 DALYs per 100 000) followed by other high-income regions.

272 e recommendations for pregnancy spacing in a high-income setting.

273 s-associated costs are not only a problem in high-income settings but also affect poorer world region

274 was smaller than in their contemporaries in high-income settings but remains stable thereafter and t

275 included in the analyses, because trials in high-income settings differ in vaccine immunogenicity an

276 ods to prevent micronutrient deficiencies in high-income settings has been demonstrated, its effectiv

277 rom post-seven-valent PCV introduction in 13 high-income settings) to predict the effect of PCV on ch

278 involved 14 countries spanning low-income to high-income settings, and cost-effectiveness ratios were

279 dence is higher in Blantyre, Malawi, than in high-income settings, from where the majority of sepsis

280 dence is higher in Blantyre, Malawi, than in high-income settings, from where the majority of sepsis

281 Compared with high-income settings, there is high residual VT carriage

282 (45.5% [35.9%-55.0%]) were roughly equal in high-income settings.

283 re severe in LMICs than has been reported in high-income settings.

284 cines is reduced in low-income compared with high-income settings.

285 tive methods, but uptake remains low even in high-income settings.

286 This was true for low/middle and high income sites.

287 Among middle-high-income students, the adjusted mean HEI-2010 prepoli

288 were low-middle-income, and 56% were middle-high-income students.

289 dle-income countries that have both low- and high-income subpopulations can provide a proxy measure f

290 eration (>14% of blindness) as causes in the high-income subregions.

291 an 5 years in England (UK), a representative high-income temperate country, and used these results to

292 In high-income, temperate countries, IgE to allergen extrac

293 s been a seismic shift in smoking rates from high-income to low- and middle-income countries (LMICs).

294 me tracts (LIN) compared to whites living in high-income tracts (HIW) and report NO(2) disparities se

295 esource extraction for their livelihood face high income variability driven by a mix of environmental

296 r person's broader social or care network in high-income versus middle-income and low-income countrie

297 The regions with the lowest prevalence were high-income western countries for boys (72.1%, 71.1-73.6

298 Whereas high-income White respondents tended to overestimate rac

299 pulation of 1 751 479 (54% women) from seven high-income WHO member countries.

300 The majority of our participants had a high income, with implications for generalizability.